Cochlear | COH - Equity Capital And Reserves

Stock Price
90.35
Daily Change
-2.65 -2.85%
Monthly
-45.87%
Yearly
-67.10%
Q2 Forecast
95.52

Cochlear reported AUD1.94B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Ansell USD 1.97B 10.2M Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Cochlear AUD 1.94B 12.2M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Fisher Paykel Healthcare NZD 1.99B 95.8M Dec/2025
Healius AUD 1.03B 13.9M Dec/2024
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Mesoblast USD 574.68M 22.76M Dec/2025
Monash IVF AUD 253.91M 3.49M Dec/2025
Nanosonics AUD 219.69M 9.78M Dec/2025
Polynovo AUD 83.14M 121K Dec/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
Regis Healthcare AUD -29.95M 13.22M Dec/2025
ResMed USD 6.32B 199.62M Dec/2025
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Somnomed AUD 22.4M 2.61M Jun/2023
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Telix Pharmaceuticals AUD 416.86M 5.08M Dec/2025